Acne Vulgaris

    January 2018 in “ Springer eBooks ”
    Gila Isman Nelkenbaum
    Image of study
    TLDR The document says that early treatment of Acne Vulgaris is important to prevent scarring and that adult onset acne is common in women, often due to hormonal imbalances.
    The document from January 1, 2018, provides a comprehensive overview of Acne Vulgaris, detailing its multifactorial pathogenesis, clinical features, and hormonal influences, with a particular focus on adult onset acne (AOA) which is more prevalent in women and often linked to hormonal imbalances such as polycystic ovary syndrome (PCOS). It describes the psychological impact of acne on individuals and emphasizes the importance of early treatment to prevent scarring. The document also discusses various forms of acne, including severe types primarily affecting adolescent males and the incidence of hidradenitis suppurativa (HS), which has a higher prevalence in women. Treatment options for AOA include hormonal therapies, oral contraceptives, corticosteroids, and anti-androgens. The document does not provide specific participant numbers from the referenced studies.
    Discuss this study in the Community →

    Research cited in this study

    7 / 7 results

    Related Community Posts Join

    6 / 934 results

      community EMA is re-examining Winlevi (clascoterone at lower concentration)

      in Treatment  8 upvotes 8 months ago
      Clascoterone in Winlevi, a topical AR antagonist, is being re-examined due to concerns about HPA axis suppression in adolescents, but it's unlikely to be banned for adult use in androgenetic alopecia (AGA). The European Medicines Agency recommended refusing Winlevi for acne vulgaris, but this may not affect Breezula's approval for AGA.

      community Finally Scalp Folliculitis-Free after 2 Decades of Suffering

      in Treatment  66 upvotes 1 year ago
      A 37-year-old male resolved scalp folliculitis by adopting a low-histamine diet and taking Vitamin A, Zinc, and Fish Oil, leading to better skin health and thicker hair. He warns about the potential toxicity of excessive Vitamin A intake.

      community Why Breezula Won’t Work for Everyone.

      in Chat  32 upvotes 2 months ago
      Breezula, a new topical hair loss treatment, is expected to be expensive, with an estimated cost of €300 per month, making it less accessible compared to cheaper alternatives like finasteride. Some users discuss the potential for cheaper generics from countries like China and India, while others debate the effectiveness and pricing strategy of Breezula compared to other treatments like minoxidil and RU58841.

      community GT20029 Anageninc Market Availability

      in Research/Science  165 upvotes 3 years ago
      The conversation discusses the potential market release of a hair loss treatment called GT20029 by Anageninc, with users expressing interest and discussing the importance of safety and effectiveness. Some users plan to contact Anageninc to show demand for the product.

      community Received Kintor’s KX-826 Today

      in Product  84 upvotes 1 year ago
      A user received Kintor’s KX-826/Pyrilutamide and shared initial impressions, noting concerns about the product's labeling and marketing. Other users discussed the legitimacy of the product, its effectiveness, and compared it to other treatments like Minoxidil and Finasteride.

    Similar Research

    5 / 1000+ results